ft 28 jan 94 uk compani news chirosci join market pound 102m tag chirosci group latest biotechnolog issu come market yesterday set flotat share price 150p give capitalis pound 102m although cambridg base group expect make profit sever year develop new drug mr peter keen financ director said investor interest exceed expect claim chirosci attract attent unlik biotechnolog compani offset loss research programm product sale compani glaxo six month august 31 sale pound 1 34m help hold interim loss pound 1 37m fund flotat incom sale call synthon chemic build block purchas larg drug compani would use develop full potenti chiral technolog research aim develop singl isom drug work faster fewer side effect twin isom product mr keen said revenu issu togeth cash reserv pound 6 9m would use market exist product enlarg workforc expand site facil flotat 30m ordinari share expect rais pound 45m pound 5m realis ventur capit compani sale 3 33m share pound 40m retain compani pound 4m use financ employe share trust condit agre purchas substanti equiti stake ventur capit sharehold robert fleme place 16 7m share institut balanc avail privat investor comment take bold compani lay claim market valuat pound 102m less two year emerg pound 1m manag buy yet chirosci done march 1992 paid pound 1m cash chiral busi enzymatix analyst expect market capitalis pound 80m describ valuat surpris warn even compani innov research techniqu begin gener profit five year time long wait investor seek capit growth nevertheless chirosci one compani develop singl isom drug fulfil promis could revolutionis part pharmaceut industri could take sever year drug realis full potenti 150p share expect open premium